ArticleTrials2023

The value of pre-symptomatic genetic risk assessment for age-related macular degeneration: the Moran AMD Genetic Testing Assessment (MAGENTA) study-a study protocol for a randomized controlled trial.

Emmanuel K Addo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.